Cargando…
Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure
The key biological “drivers” that are responsible for reverse left ventricle (LV) remodeling are not well understood. To gain an understanding of the role of the autophagy-lysosome pathway in reverse LV remodeling, we used a pathophysiologically relevant murine model of reversible heart failure, whe...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831862/ https://www.ncbi.nlm.nih.gov/pubmed/36644282 http://dx.doi.org/10.1016/j.jacbts.2022.06.003 |
_version_ | 1784867938309767168 |
---|---|
author | Evans, Sarah Ma, Xiucui Wang, Xiqiang Chen, Yana Zhao, Chen Weinheimer, Carla J. Kovacs, Attila Finck, Brian Diwan, Abhinav Mann, Douglas L. |
author_facet | Evans, Sarah Ma, Xiucui Wang, Xiqiang Chen, Yana Zhao, Chen Weinheimer, Carla J. Kovacs, Attila Finck, Brian Diwan, Abhinav Mann, Douglas L. |
author_sort | Evans, Sarah |
collection | PubMed |
description | The key biological “drivers” that are responsible for reverse left ventricle (LV) remodeling are not well understood. To gain an understanding of the role of the autophagy-lysosome pathway in reverse LV remodeling, we used a pathophysiologically relevant murine model of reversible heart failure, wherein pressure overload by transaortic constriction superimposed on acute coronary artery (myocardial infarction) ligation leads to a heart failure phenotype that is reversible by hemodynamic unloading. Here we show transaortic constriction + myocardial infarction leads to decreased flux through the autophagy-lysosome pathway with the accumulation of damaged proteins and organelles in cardiac myocytes, whereas hemodynamic unloading is associated with restoration of autophagic flux to normal levels with incomplete removal of damaged proteins and organelles in myocytes and reverse LV remodeling, suggesting that restoration of flux is insufficient to completely restore myocardial proteostasis. Enhancing autophagic flux with adeno-associated virus 9–transcription factor EB resulted in more favorable reverse LV remodeling in mice that had undergone hemodynamic unloading, whereas overexpressing transcription factor EB in mice that have not undergone hemodynamic unloading leads to increased mortality, suggesting that the therapeutic outcomes of enhancing autophagic flux will depend on the conditions in which flux is being studied. |
format | Online Article Text |
id | pubmed-9831862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-98318622023-01-12 Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure Evans, Sarah Ma, Xiucui Wang, Xiqiang Chen, Yana Zhao, Chen Weinheimer, Carla J. Kovacs, Attila Finck, Brian Diwan, Abhinav Mann, Douglas L. JACC Basic Transl Sci Original Research - Preclinical The key biological “drivers” that are responsible for reverse left ventricle (LV) remodeling are not well understood. To gain an understanding of the role of the autophagy-lysosome pathway in reverse LV remodeling, we used a pathophysiologically relevant murine model of reversible heart failure, wherein pressure overload by transaortic constriction superimposed on acute coronary artery (myocardial infarction) ligation leads to a heart failure phenotype that is reversible by hemodynamic unloading. Here we show transaortic constriction + myocardial infarction leads to decreased flux through the autophagy-lysosome pathway with the accumulation of damaged proteins and organelles in cardiac myocytes, whereas hemodynamic unloading is associated with restoration of autophagic flux to normal levels with incomplete removal of damaged proteins and organelles in myocytes and reverse LV remodeling, suggesting that restoration of flux is insufficient to completely restore myocardial proteostasis. Enhancing autophagic flux with adeno-associated virus 9–transcription factor EB resulted in more favorable reverse LV remodeling in mice that had undergone hemodynamic unloading, whereas overexpressing transcription factor EB in mice that have not undergone hemodynamic unloading leads to increased mortality, suggesting that the therapeutic outcomes of enhancing autophagic flux will depend on the conditions in which flux is being studied. Elsevier 2022-10-19 /pmc/articles/PMC9831862/ /pubmed/36644282 http://dx.doi.org/10.1016/j.jacbts.2022.06.003 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research - Preclinical Evans, Sarah Ma, Xiucui Wang, Xiqiang Chen, Yana Zhao, Chen Weinheimer, Carla J. Kovacs, Attila Finck, Brian Diwan, Abhinav Mann, Douglas L. Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure |
title | Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure |
title_full | Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure |
title_fullStr | Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure |
title_full_unstemmed | Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure |
title_short | Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure |
title_sort | targeting the autophagy-lysosome pathway in a pathophysiologically relevant murine model of reversible heart failure |
topic | Original Research - Preclinical |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831862/ https://www.ncbi.nlm.nih.gov/pubmed/36644282 http://dx.doi.org/10.1016/j.jacbts.2022.06.003 |
work_keys_str_mv | AT evanssarah targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure AT maxiucui targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure AT wangxiqiang targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure AT chenyana targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure AT zhaochen targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure AT weinheimercarlaj targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure AT kovacsattila targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure AT finckbrian targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure AT diwanabhinav targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure AT manndouglasl targetingtheautophagylysosomepathwayinapathophysiologicallyrelevantmurinemodelofreversibleheartfailure |